Global Cardiovascular Ultrasound Market Overview:
A Cardiovascular Ultrasound is known as a tool which is used to evaluate the function and structure of the heart and associated vessels. It is easy and fast, a painless evaluation which uses ultrasound waves for producing images of the heart. In North America, the test is been performed by a technologist who is specially trained, called a sonographer, and is interpreted by a physician who is specially-trained, usually, a cardiologist is trained in reading Cardiovascular Ultrasound. Cardiovascular Ultrasound provides the patient's doctor with moving pictures of his heart that allows his doctor to evaluate the heart’s health. Some of the factors like high quality and real-life images produced by 3d cardiovascular ultrasound and benefits associated with cardiovascular ultrasound over conventional methods are driving the market while growing end-user preference for refurbished equipment and the dearth of skilled and well-trained sonographers is challenging the market for its growth.
Market Drivers
- Increase In the Incidence of Cardiovascular Diseases and Changing Lifestyle
- High Quality and Real Life Images Produced By 3d Cardiovascular Ultrasound
- Benefits Associated With Cardiovascular Ultrasound over Conventional Methods
Market Trend
- Rise in Funding Grants for Product Development
Restraints
- Stringent Government Rules and Regulations
- High Cost Associated with Cardiovascular Ultrasound
Opportunities
- Increase in Demand for Cardiovascular Ultrasound Imaging System in Hospitals
- Cost Optimization in Manufacturing of Devices
Challenges
- Growing End-User Preference for Refurbished Equipment
- Dearth of Skilled and Well-Trained Sonographers
Competitive Landscape:
Product launches help companies in expanding their product ranges and in penetrating various regions to strengthen their market presence. With an increasing number of product approvals and launches in the market, more vendors are focusing on developing next-generation systems for Cardiovascular Ultrasound. It helps vendors sustain intense competition in the market and expand their product portfolio.
Some of the key players profiled in the report are GE Healthcare (United States), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan), SAMSUNG (South Korea), FUJIFILM Holdings (Japan), Esaote (Italy), Shenzhen Mindray Bio-Medical Electronics (China) and Analogic (United States). Considering Market by Technology, the sub-segment i.e. 2D will boost the Cardiovascular Ultrasound market. Considering Market by Display, the sub-segment i.e. B/W will boost the Cardiovascular Ultrasound market.
Market Highlights:
In March 2018, GE Healthcare is a multinational company which provides medical imaging, monitoring, biomanufacturing and cell and gene therapy technologies (US) has expanded with Trice Imaging (US) their partnership for software enhancements and developments to be made for GE’s LOGIQ E10 ultrasound system.
GE Healthcare, had received clearance from the Food and Drug Administration (FDA) for its Vivid T8TM cardiovascular ultrasound device. As per reports, GE had enhanced the reach of the Vivid T8 by combining the established cardiac imaging capabilities of GE Vivid systems with exceptional performance of the company’s LOGIQTM systems
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cardiovascular Ultrasound market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cardiovascular Ultrasound market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Cardiovascular Ultrasound Devices Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.